Biotech FP&A Director: R&D Budgeting & Strategy (Remote)

Immunovant; Durham (NC); Remote; USD 200,000 - 240,000; Full time

Benefits offered by this job

401k

Unlimited paid time off

Parental leave

Job summary

Immunovant, Inc. is seeking a senior FP&A professional to serve as the primary finance business partner for Research & Development.

You will own planning, forecasting, and reporting for the clinical development portfolio, partnering with program leadership to translate strategy into actionable budgets. Reporting to the CFO, you will build annual budgets, quarterly forecasts, and month-end close processes, delivering timely analytics to inform senior leadership and Board materials.

Qualifications

• 7+ years of experience in financial planning and analysis, investment banking, or consulting
• Strong modeling and Excel skills with the ability to translate complex analyses into actionable insights
• Excellent written and verbal communication in a virtual environment
• Ability to meet tight deadlines in a fast-paced setting and work independently
• BA or BS degree required

Responsibilities

• Own development and monitoring of annual budgets and quarterly forecasts for R&D
• Lead month-end reporting of actual results for Research & Development
• Develop and maintain trial-level clinical cost models and associated assumptions
• Support CFO with multi-year strategic plans and Board materials
• Provide timely financial guidance and analytics to inform decision making

Skills

Financial planning

Forecasting

Analytical thinking

Advanced Excel modeling

Communication

Education

Bachelor's degree

MBA preferred

Tools

Adaptive

Coupa

NetSuite

Job description

Immunovant, Inc. is seeking a senior FP&A professional to serve as the primary finance business partner for Research & Development.

You will own planning, forecasting, and reporting for the clinical development portfolio, partnering with program leadership to translate strategy into actionable budgets. Reporting to the CFO, you will build annual budgets, quarterly forecasts, and month-end close processes, delivering timely analytics to inform senior leadership and Board materials.